Sling Therapeutics Launches With $35M Series A Financing To Develop Oral Small Molecule For Thyroid Eye Disease
Amount Raised
$35 Million
Round Type
Series A
Ann ArborBiotechnologyHealth CareDescription
Sling Therapeutics, Inc., a biopharmaceutical company focused on late-stage development of an oral small molecule for the treatment of thyroid eye disease (TED), today announced the official launch of the company with a $35M Series A financing led by TPG's The Rise Fund. The funds will support a Phase 2b clinical trial evaluating the company's investigational drug, linsitinib, for the treatment of TED.
Quick answer
Sling Therapeutics raised $35 Million in a Series A round, dated June 13, 2022. Sling Therapeutics is based in Ann Arbor, Michigan, United States.
- How much did Sling Therapeutics raise?
- Sling Therapeutics raised $35 Million in a Series A round on June 13, 2022.
- What does Sling Therapeutics do?
- Sling Therapeutics is a clinical-stage biopharmaceutical company focused on developing an oral small molecule therapy for the treatment of thyroid eye disease (TED).
- Where is Sling Therapeutics based and how big is it?
- Sling Therapeutics is based in Ann Arbor, Michigan, United States. Fundz records about 10 employees.
- Who are the decision-makers at Sling Therapeutics?
- Fundz holds 1 contact at Sling Therapeutics. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Biotechnology and Health Care around the same time
Companies in the same sectors as Sling Therapeutics that raised within 45 days of this round, from Fundz verified event records.
- Diagnostic Robotics raised $45M (Series B) on July 28, 2022.
- Core Biogenesis raised $11M (Funding Round) on July 28, 2022.
- Vicinitas Therapeutics raised $65M (Series A) on July 28, 2022.
- Suvera raised $6.5M (Funding Round) on July 28, 2022.
- Elevation Oncology raised $50M (Debt Financing) on July 28, 2022.
- Syapse Holdings raised $35M on July 27, 2022.
Who to call at Sling Therapeutics, and when
A new round usually means Sling Therapeutics is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Sling Therapeutics raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Sling Therapeutics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Sling Therapeutics. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Sling Therapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Funding Insights
What this usually meansSling Therapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.